“[Budget Impact Analysis of Empagliflozin for the Treatment of Type 2 Diabetes in Italy]”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 17, no. 1, Mar. 2016, pp. 19-27, https://doi.org/10.7175/fe.v17i1.1238.